TISSUE DONATION IS CRITICAL TO FIND TREATMENTS! Click here to learn more.
Clinical Trials
A clinical trial is a type of research that studies a test, treatment, or other intervention according to a research plan. This may include drugs that are not yet approved by the FDA, drugs that are already approved and are being investigated for new or different purposes, comparisons of drugs, devices or procedures, or other types of interventions.
Observational studies are another type of research study where doctors assess health outcomes of participants. These studies are done as a part of routine care and help researchers understand the effects of a treatment, procedure or other lifestyle change.
When considering participation in a clinical trial or any other research we urge you to consult your physician or other qualified medical resource as well as the person who is conducting the research study to answer any questions you have. The information provided here is for information only and is not intended as medical advice or a recommendation.
Below are currently active clinical trials of EHE in the United States. To see the details and contacts for each study, click on the ClinicalTrials.gov identifier.
To learn more about the phases of clinical trials go to cancer.org.
Stay Informed
Get email alerts about the latest treatments, research advances, and opportunities to get involved.
| ClinicalTrials.gov Identifier | Study Title / Phase | Location(s) | Principal Investigator |
|---|---|---|---|
| NCT04028063 | Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas - Phase 2 | Aurora, Colorado | Breelyn Wilky, MD |
| NCT04784247 | Lenvatinib and Pembrolizumab in People with Advanced Soft Tissue Sarcoma - Phase 2 | NY & NJ Locations | Sandra D'Angelo, MD |
| NCT04577014 | INCMGA00012 (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients with Advanced Soft Tissue Sarcoma - Phase 1/2 | New York, NY | Sandra D'Angelo, MD |
Phase 1 Clinical Trials
Phase 1 clinical trials (studies) are the first step in testing new drug candidates in humans. These studies are done primarily to test safety, side effects, and the best dose of a potential new treatment. Some study participants may benefit from the drug candidate being tested; however, disease response is not the primary purpose of phase 1 studies. To find out more about these studies, contact our research team.
To learn more about the phases of clinical trials go to cancer.org.
| ClinicalTrials.gov Identifier | Study Title / Phase | Location(s) |
|---|---|---|
| NCT05228015 | Phase I Study: Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors | Multiple Locations |
| NCT04857372 | Phase I Study: IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors | Multiple Locations |